Log in
Enquire now
‌

US Patent 10730821 Site-specific isotopic labeling of 1,4-diene systems

Patent 10730821 was granted and assigned to Retrotope Inc. on August, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Retrotope Inc.
Retrotope Inc.
0
Date Filed
September 9, 2016
0
Date of Patent
August 4, 2020
0
Patent Applicant
Retrotope Inc.
Retrotope Inc.
0
Patent Application Number
15778182
0
Patent Citations Received
‌
US Patent 12109194 Synergistic combination therapy for treating ALS
0
‌
US Patent 11510889 Methods for inhibiting the progression of neurodegenerative diseases
‌
US Patent 11447441 Site-specific isotopic labeling of 1,4-diene systems
‌
US Patent 12060324 Site-specific isotopic labeling of 1,4-diene systems
0
‌
US Patent 11491130 Methods of treating amyotrophic lateral sclerosis
‌
US Patent 11779910 Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10730821
0
Patent Primary Examiner
‌
Paul A. Zucker
0

Find more entities like US Patent 10730821 Site-specific isotopic labeling of 1,4-diene systems

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.